Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7668490B2 - Disinfectant - Google Patents
[go: Go Back, main page]

JP7668490B2 - Disinfectant - Google Patents

Disinfectant Download PDF

Info

Publication number
JP7668490B2
JP7668490B2 JP2021169593A JP2021169593A JP7668490B2 JP 7668490 B2 JP7668490 B2 JP 7668490B2 JP 2021169593 A JP2021169593 A JP 2021169593A JP 2021169593 A JP2021169593 A JP 2021169593A JP 7668490 B2 JP7668490 B2 JP 7668490B2
Authority
JP
Japan
Prior art keywords
solution
disinfectant
bacteria
carbonated water
gse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021169593A
Other languages
Japanese (ja)
Other versions
JP2023059530A (en
JP2023059530A5 (en
Inventor
啓太 新屋
宏 多丸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RYUKYU-WONDER LIMITED LIABILITY COMPANY
Original Assignee
RYUKYU-WONDER LIMITED LIABILITY COMPANY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RYUKYU-WONDER LIMITED LIABILITY COMPANY filed Critical RYUKYU-WONDER LIMITED LIABILITY COMPANY
Priority to JP2021169593A priority Critical patent/JP7668490B2/en
Priority to PCT/JP2022/038075 priority patent/WO2023063361A1/en
Priority to TW111138978A priority patent/TW202330008A/en
Publication of JP2023059530A publication Critical patent/JP2023059530A/en
Publication of JP2023059530A5 publication Critical patent/JP2023059530A5/ja
Application granted granted Critical
Publication of JP7668490B2 publication Critical patent/JP7668490B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/36Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dentistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、グレープフルーツ種子抽出物に由来する除菌成分を含む除菌液に関する。 The present invention relates to a disinfectant solution containing a disinfectant component derived from grapefruit seed extract.

従来から、除菌や消毒用の液剤として、アルコール類又は次亜塩素酸ナトリウム等の塩素系の除菌成分を含むものが用いられている。一方、これら成分は、人体に接触すると皮膚トラブルの要因となる等、使用時の取り扱いに注意を要することから、植物由来の除菌成分を用いることが検討されている。このような成分として、除菌作用を有するグレープフルーツ種子抽出物(以下、適宜、GSEと称する)が知られている。 Conventionally, liquid agents for sterilization and disinfection have been used that contain alcohols or chlorine-based sterilizing ingredients such as sodium hypochlorite. However, these ingredients require careful handling when used, as they can cause skin problems if they come into contact with the human body, and so the use of plant-derived sterilizing ingredients has been considered. One such ingredient known to have sterilizing properties is grapefruit seed extract (hereinafter, appropriately referred to as GSE).

例えば、特許文献1には、GSEを水に溶かし、フィチン酸を加えた上で、醸造用アルコールを加えてなり、GSEが0.07~0.09質量%、フィチン酸が0.04~0.06質量%、醸造用アルコールが58~59.9質量%、残りが水となるように調製された除菌液が開示されている。この除菌液は、ノロウイルスと形態的な特徴が近縁なウイルスであるネコカリシウイルスに対して、醸造用アルコールのみの場合よりも高い不活化効果を示している。 For example, Patent Document 1 discloses a disinfectant solution prepared by dissolving GSE in water, adding phytic acid, and then adding brewer's alcohol, with the solution being 0.07-0.09% by mass of GSE, 0.04-0.06% by mass of phytic acid, 58-59.9% by mass of brewer's alcohol, and the remainder being water. This disinfectant solution exhibits a higher inactivation effect against feline calicivirus, a virus morphologically closely related to norovirus, than brewer's alcohol alone.

また、特許文献2には、GSEの水溶液に、緩衝剤が含有されて、pH8以上に調整されているウイルス不活性化剤が開示されている。緩衝剤としては、炭酸ナトリウム及び炭酸水素ナトリウムが用いられ、水溶液が緩衝液となって安定化し、弱アルカリ領域でのウイルス不活性化剤の経時安定性が得られることが記載されている。 Patent Document 2 also discloses a virus inactivator in which a buffer is contained in an aqueous solution of GSE, and the pH is adjusted to 8 or higher. Sodium carbonate and sodium bicarbonate are used as the buffer, and it is described that the aqueous solution becomes a buffer solution and is stabilized, and that the virus inactivator can be stabilized over time in the weak alkaline range.

特開2007-320924号公報JP 2007-320924 A 特開2021-059512号公報JP 2021-059512 A

近年、一般用又は医療用の除菌液の需要が増加しており、より除菌力が高く、安全性及び取扱性にも優れた除菌液が望まれている。しかしながら、特許文献1、2に記載される液剤は、いずれもノロウイルス等のウイルス不活性化に対する効果は示されているものの、より高い除菌力が要求される、例えば、芽胞を形成する細菌(以下、適宜、芽胞菌と称する)に対する効果は確認されていない。また、特許文献1の除菌液は、アルコールを主体とする液剤であり、安全性、取扱性に難がある。 In recent years, the demand for disinfectant solutions for general or medical use has been increasing, and there is a demand for disinfectant solutions with stronger disinfecting power and excellent safety and ease of handling. However, while the liquid preparations described in Patent Documents 1 and 2 have both been shown to be effective in inactivating viruses such as norovirus, their effectiveness against bacteria that form spores (hereinafter, appropriately referred to as spore-forming bacteria), for which a higher disinfecting power is required, has not been confirmed. In addition, the disinfectant solution in Patent Document 1 is a liquid preparation mainly composed of alcohol, which has problems with safety and ease of handling.

本発明は、かかる背景に鑑みてなされたものであり、高い除菌力を有し、安全性及び取扱性に優れた除菌液を提供しようとするものである。 The present invention was made in light of this background, and aims to provide a disinfectant liquid that has high disinfecting power, is safe, and is easy to handle.

本発明の一態様は、微細バブルを含む炭酸水と、グレープフルーツ種子抽出物の原液との混合液からなり、
上記炭酸水は、二酸化炭素濃度が300mg/L以上の高濃度炭酸水であり、
上記グレープフルーツ種子抽出物の原液は、1mg/100g以上のポリフェノール及び30mg/100g以上のクエン酸を含むものであり、
上記混合液は、pHが7未満であり、
上記混合液における、上記グレープフルーツ種子抽出物の原液の配合割合が、1体積%以上である、除菌液にある。
One aspect of the present invention is a mixture of carbonated water containing fine bubbles and an undiluted solution of grapefruit seed extract,
The carbonated water is high-concentration carbonated water having a carbon dioxide concentration of 300 mg/L or more.
The grapefruit seed extract concentrate contains 1 mg/100 g or more of polyphenols and 30 mg/100 g or more of citric acid,
The mixture has a pH of less than 7;
The blending ratio of the grapefruit seed extract concentrate in the mixed solution is 1 volume % or more to form a sterilization solution.

炭酸水に、除菌成分として、グレープフルーツ種子抽出物に由来するポリフェノールが添加された除菌液は、一般的な細菌類に対する除菌作用や抗ウイルス作用のみならず、芽胞菌に対しても高い除菌力を示すことが判明した。その理由は、必ずしも明らかではないが、炭酸水に含まれる気泡が、異物である菌やウイルスの表面に付着して破裂する際に、それらの表面を覆う皮膜を破壊する作用を有し、さらに、皮膜破壊された菌やウイルスに、除菌成分が速やかに作用して、除菌が進行するものと考えられる。また、炭酸水が、除菌液のpHを調整する作用を有して、除菌に好適な環境を形成し、炭酸水に含まれる気泡が電荷を帯びて菌やウイルスを吸着しやすくなること等が寄与して、種々の菌やウイルスの除去を可能にするものと推察される。 It has been found that a disinfectant liquid in which polyphenols derived from grapefruit seed extract are added as a disinfectant component to carbonated water not only has disinfectant and antiviral effects against general bacteria, but also has a high disinfecting power against spore-forming bacteria. The reason for this is not entirely clear, but it is thought that when the air bubbles contained in the carbonated water adhere to the surface of foreign bodies such as bacteria and viruses and burst, they have the effect of destroying the membrane that covers their surface, and further, the disinfectant component acts quickly on the bacteria and viruses whose membranes have been destroyed, progressing the disinfection. It is also presumed that the carbonated water has the effect of adjusting the pH of the disinfectant liquid, forming an environment suitable for disinfection, and that the air bubbles contained in the carbonated water are electrically charged and easily adsorb bacteria and viruses, contributing to the removal of various bacteria and viruses.

以上のごとく、上記態様によれば、高い除菌力を有し、安全性及び取扱性に優れた除菌液を提供することができる。 As described above, the above embodiment provides a disinfectant solution that has high disinfecting power, and is safe and easy to handle.

以下に、除菌液に係る実施形態について、詳細に説明する。
本実施形態において、除菌液は、炭酸水と、グレープフルーツ種子抽出物に由来する(以下、グレープフルーツ種子抽出物由来と略称する)ポリフェノールとを含む水性液剤である。好適には、炭酸水は、微細バブルを含む。また、好適には、除菌液は、二酸化炭素濃度が、250mg/L以上となるように調製されている。
Hereinafter, an embodiment relating to the disinfectant solution will be described in detail.
In this embodiment, the disinfectant solution is an aqueous liquid agent containing carbonated water and polyphenols derived from grapefruit seed extract (hereinafter, abbreviated as grapefruit seed extract-derived). Preferably, the carbonated water contains fine bubbles. Also, preferably, the disinfectant solution is prepared so that the carbon dioxide concentration is 250 mg/L or more.

好ましくは、除菌液は、pHが7未満となるように調製されており、より好ましくは、弱酸性水溶液となるように、例えば、pHが4.5以上6以下の範囲に調製されている。除菌液に含まれる炭酸水は、除菌液を弱酸性領域に調整する緩衝作用を有し、微細バブル状の二酸化炭素を所定濃度で含むことにより、除菌液を所定の弱酸性領域に安定して維持する。また、除菌液は、グレープフルーツ種子抽出物由来のクエン酸を、さらに含むことができる。クエン酸は、除菌液のpHを調整する作用を有する。 Preferably, the disinfectant liquid is prepared to have a pH of less than 7, and more preferably, to be a weakly acidic aqueous solution, for example, a pH in the range of 4.5 to 6. The carbonated water contained in the disinfectant liquid has a buffering effect that adjusts the disinfectant liquid to a weakly acidic region, and by containing finely bubbled carbon dioxide at a predetermined concentration, the disinfectant liquid is stably maintained in a predetermined weakly acidic region. The disinfectant liquid may further contain citric acid derived from grapefruit seed extract. Citric acid has the effect of adjusting the pH of the disinfectant liquid.

グレープフルーツ種子抽出物(GSE;grapefruit seed extract)は、柑橘類であるグレープフルーツの種子の抽出物であり、例えば、種子の粉砕物から溶媒を用いて抽出される。GSEは、脂肪酸及びフラボノイド(ポリフェノール)を主成分とする食品添加物として知られており、これら成分の他、クエン酸等を含んでいる。クエン酸も、食品添加物として認められている。GSE(原液)は、例えば、1mg/100g以上のポリフェノールを含み、また、30mg/100g以上のクエン酸を含むものが、好適に用いられる。 Grapefruit seed extract (GSE) is an extract of the seeds of grapefruit, a citrus fruit, and is extracted, for example, from crushed seeds using a solvent. GSE is known as a food additive whose main components are fatty acids and flavonoids (polyphenols), and in addition to these components, it also contains citric acid, etc. Citric acid is also recognized as a food additive. GSE (undiluted solution) that contains, for example, 1 mg/100 g or more of polyphenols and 30 mg/100 g or more of citric acid is preferably used.

炭酸水は、二酸化炭素(CO)ガスを水に混合して得られる水性液であり、マイクロバブル又はナノバブルのサイズの微細バブルを含むことが好ましい。マイクロバブルは、通常、直径が1μm以上100μm以下の気泡のことであり、ナノバブルは、直径が1μm未満の気泡のことを言う。微細バブルの粒子径及び個数の測定は、例えば、マイクロバブルについては、画像解析式粒子径分布測定装置等によって測定することができる。また、ナノバブルは、レーザ光の散乱を用いた動的光散乱法、粒子追跡法、レーザ回折・散乱法等により測定することができる。 Carbonated water is an aqueous liquid obtained by mixing carbon dioxide (CO 2 ) gas with water, and preferably contains fine bubbles of the size of microbubbles or nanobubbles. Microbubbles are usually bubbles with a diameter of 1 μm or more and 100 μm or less, and nanobubbles are bubbles with a diameter of less than 1 μm. The particle size and number of fine bubbles can be measured, for example, for microbubbles, using an image analysis type particle size distribution measuring device, etc. Furthermore, nanobubbles can be measured by a dynamic light scattering method using scattering of laser light, a particle tracking method, a laser diffraction/scattering method, etc.

このような微細バブルは、除菌液に安定して溶存し、所望の二酸化炭素濃度を維持することができる。また、微細バブルは、除菌液中において、例えば、マイナスに帯電して、菌又はウイルスを吸着しやすくなると共に、それらの表面の皮膜を破壊して、除菌成分が菌又はウイルスに作用するのを補助する機能を有すると考えられる。さらに、微細バブルが除菌液中に安定して存在することにより、除菌液のpHが安定し、除菌液の効果を長期間維持することが可能になる。 Such fine bubbles are stably dissolved in the disinfectant liquid, and can maintain the desired carbon dioxide concentration. In addition, the fine bubbles are negatively charged in the disinfectant liquid, for example, and are thought to have the function of easily adsorbing bacteria or viruses and destroying the coating on their surfaces, thereby assisting the disinfecting components in acting on the bacteria or viruses. Furthermore, the stable presence of fine bubbles in the disinfectant liquid stabilizes the pH of the disinfectant liquid, making it possible to maintain the effectiveness of the disinfectant liquid for a long period of time.

除菌液は、好適には、二酸化炭素濃度が、250mg/L以上となるように調製されており、より微細なバブル状の二酸化炭素がより多く溶存することにより、菌又はウイルスに対する接触確率が高くなり、除菌又はウイルス不活性化に有利に作用する。二酸化炭素濃度が250mg/L~300mg/L程度ないし以上の炭酸水は、一般に、温泉法による炭酸泉とされる濃度のものであり、常温で天然に存在する濃度よりも高い。 The disinfectant solution is preferably prepared so that the carbon dioxide concentration is 250 mg/L or more. The presence of more finely-dissolved carbon dioxide bubbles increases the probability of contact with bacteria or viruses, which is advantageous for disinfection or virus inactivation. Carbonated water with a carbon dioxide concentration of about 250 mg/L to 300 mg/L or more is generally considered to be a carbonated spring according to the Hot Springs Act, and is a higher concentration than that which exists naturally at room temperature.

二酸化炭素は、予め所定濃度で水に溶存させた炭酸水として、GSEと混合することができる。水は、一般の水道水、天然水、蒸留水等の任意のものを用いることができる。炭酸水の二酸化炭素濃度は、300mg/L以上、好適には、500mg/L以上であることが好ましく、除菌液の二酸化炭素濃度を所望の濃度に調整可能となる。 Carbon dioxide can be dissolved in water at a predetermined concentration in advance to form carbonated water, which can be mixed with GSE. Any water can be used, such as ordinary tap water, natural water, or distilled water. The carbon dioxide concentration of the carbonated water is preferably 300 mg/L or more, and more preferably 500 mg/L or more, making it possible to adjust the carbon dioxide concentration of the sterilizing liquid to the desired concentration.

炭酸水の調製方法は、特に制限されず、微細バブルが所望の濃度で含まれるように、二酸化炭素を水に混合して溶解させる方法であればよい。その際、炭酸水に溶存可能な二酸化炭素の量は、圧力によって制限され、例えば、大気圧においては、1000mg/L程度が上限となる。そのため、好適には、炭酸水の製造時の圧力を大気圧よりも高くし、加圧下にて混合を行うことにより、溶存可能な二酸化炭素の量を増加させることができる。通常は、炭酸水の二酸化炭素濃度が、1000mg/L以上1300mg/L以下の範囲となるように調整されることが好ましい。 There are no particular limitations on the method for preparing carbonated water, and any method can be used as long as carbon dioxide is mixed and dissolved in water so that fine bubbles are contained at the desired concentration. In this case, the amount of carbon dioxide that can be dissolved in carbonated water is limited by pressure, and at atmospheric pressure, for example, the upper limit is about 1000 mg/L. Therefore, it is preferable to increase the amount of carbon dioxide that can be dissolved by making the pressure during production of carbonated water higher than atmospheric pressure and mixing under pressure. Usually, it is preferable to adjust the carbon dioxide concentration of the carbonated water to be in the range of 1000 mg/L or more and 1300 mg/L or less.

炭酸水とGSEとを混合して除菌液とする際には、その除菌作用を有効に発揮するという観点から、GSEの原液を用い、その配合割合を、0.1体積%以上とすることが望ましい。また、GSEの原液の配合割合の上限は、特に制限されないが、25体積%以下の範囲であれば、実用上十分な効果が得られる。好適には、GSEの配合割合を、1体積%以上10体積%以下の範囲で、所望の除菌効果が得られるように、適宜設定することができる。 When mixing carbonated water and GSE to make a disinfectant solution, it is desirable to use a concentrate of GSE and set the mixing ratio at 0.1% by volume or more in order to effectively exert the disinfecting action. There is no particular upper limit to the mixing ratio of the concentrate of GSE, but a range of 25% by volume or less will provide sufficient practical effects. Preferably, the mixing ratio of GSE can be appropriately set in the range of 1% by volume or more and 10% by volume or less so that the desired disinfecting effect can be obtained.

このようにして得られた除菌液は、天然由来の成分のみを使用した水性液剤であり、安全性が高い。また、取扱性にも優れており、直接使用することもできるが、必要により又は用途に応じて、水道水等の水で希釈して使用することもできる。その場合には、スプレーボトル等に除菌液を入れて所望の希釈率となるように水を追加し、あるいは、加湿器のタンク等に入れた水に除菌液を添加して、ミスト状に噴霧して使用することができる。 The disinfectant solution obtained in this way is an aqueous liquid agent using only naturally derived ingredients, and is highly safe. It is also easy to handle and can be used directly, but it can also be diluted with water, such as tap water, if necessary or depending on the application. In that case, the disinfectant solution can be placed in a spray bottle or the like and water added to achieve the desired dilution ratio, or the disinfectant solution can be added to water in a humidifier tank or the like and sprayed in the form of a mist.

以上のように、本形態の除菌液は、微細バブル状の二酸化炭素が溶存している炭酸水に、グレープフルーツ種子抽出物由来の除菌成分が添加されたものであり、一般的な細菌類に対する除菌作用や抗ウイルス作用のみならず、芽胞菌に対しても高い除菌力を示す。また、安全性及び取扱性に優れており、除菌液として有用である。 As described above, the disinfectant liquid of this embodiment is made by adding a disinfectant component derived from grapefruit seed extract to carbonated water in which fine carbon dioxide bubbles are dissolved, and it not only has disinfectant and antiviral effects against general bacteria, but also has high disinfecting power against spore-forming bacteria. It is also safe and easy to handle, making it useful as a disinfectant liquid.

このような効果が得られる理由は、必ずしも明らかではないが、除菌液に含まれる微細バブルが、電荷を帯びて菌やウイルスを吸着しやすくなっており、異物である菌やウイルスの表面に付着すると、破裂してそれらの皮膜を破壊する作用を有することが大きく寄与していると考えられる。それにより、皮膜破壊された菌やウイルスに、除菌成分が作用しやすくなり、速やかに除菌が進行するものと考えられる。また、微細バブルが除菌液中に安定して存在し、pHを弱酸性領域でほぼ一定に維持する緩衝作用を有して、除菌に好適な環境を形成していること等が寄与して、種々の菌やウイルスの除去を可能にするものと推察される。 The reason why such an effect is obtained is not entirely clear, but it is believed that a major contributing factor is that the fine bubbles contained in the disinfectant liquid are electrically charged and therefore easily adsorb bacteria and viruses, and when they adhere to the surface of foreign bacteria or viruses, they burst and destroy their coating. This makes it easier for the disinfectant components to act on the bacteria and viruses whose coatings have been destroyed, and disinfection proceeds quickly. It is also believed that the fine bubbles are stable in the disinfectant liquid, have a buffering effect that keeps the pH almost constant in the weak acidic range, and form an environment suitable for disinfection, which contributes to making it possible to remove various bacteria and viruses.

以下に、除菌液の実施例と、比較例又は参考例において行った各種菌又はウイルスに対する抗菌試験又はウイルス不活性化試験とその結果を示して、本発明をさらに詳細に説明する。ただし、本発明は、以下の実施例に限定されるものではない。 The present invention will be explained in more detail below by showing examples of the disinfectant solution, as well as antibacterial tests or virus inactivation tests conducted on various bacteria or viruses in comparative examples or reference examples, and the results thereof. However, the present invention is not limited to the following examples.

(実施例1~3)
以下のようにして、グレープフルーツ種子抽出物の原液(以下、GSE原液)と、微細バブルを含む高濃度炭酸水との混合液からなる除菌液を調製し、得られた除菌液の効果を確認するための試験を行った。GSE原液としては、表1、表2に示す成分組成を有する市販品を用いた。表1に示されるように、GSE原液は、除菌成分としてのポリフェノールと、脂質(脂肪酸)の他に、クエン酸と、フルクトース、タンパク質とを含んでいる。表2は、表1における脂質を構成している脂肪酸組成を示している。
(Examples 1 to 3)
A disinfecting solution consisting of a mixture of grapefruit seed extract stock solution (hereinafter, GSE stock solution) and high-concentration carbonated water containing fine bubbles was prepared as follows, and a test was conducted to confirm the effect of the obtained disinfecting solution. As the GSE stock solution, a commercially available product having the component composition shown in Tables 1 and 2 was used. As shown in Table 1, the GSE stock solution contains polyphenols as disinfecting components, lipids (fatty acids), as well as citric acid, fructose, and proteins. Table 2 shows the fatty acid composition constituting the lipids in Table 1.

微細バブルを含む炭酸水は、水道水と二酸化炭素ガスとを、0.35MPaの圧力下で混合することにより、二酸化炭素濃度が1000mg/Lとなるように調製された高濃度炭酸水を用いた。このようにして調製された炭酸水は、レーザ光の散乱を用いた粒子径測定装置により、粒子径1μm未満のナノバブルを、1.9~2.0×107 個/ml含むことが確認された。 The carbonated water containing fine bubbles was high-concentration carbonated water prepared by mixing tap water and carbon dioxide gas under a pressure of 0.35 MPa to give a carbon dioxide concentration of 1000 mg/L. It was confirmed by a particle size measuring device using scattering of laser light that the carbonated water prepared in this manner contained nanobubbles with particle sizes of less than 1 μm at 1.9 to 2.0 x 107 pieces/mL.

また、このようにして調製された炭酸水は、水道水のpH(通常、5.8~8.6の範囲)によらず、高濃度炭酸水のpHが5程度に保たれることが確認された。pH10のアルカリ性水に二酸化炭素を混合した場合も、高濃度炭酸水の緩衝作用により、pHが6前後となることが確認された。 It was also confirmed that the carbonated water prepared in this way maintains a pH of about 5, regardless of the pH of tap water (usually in the range of 5.8 to 8.6). It was also confirmed that even when carbon dioxide is mixed with alkaline water of pH 10, the pH remains around 6 due to the buffering effect of the carbonated water.

上記のようにして得た高濃度炭酸水500mlに、2体積%の含有割合となるように、GSE原液を混合して、試験用の除菌液を得た。この試験用の除菌液を用いて、混釈平板培養法により、芽胞菌に対する除菌効果を確認するための抗菌試験を行った。除菌液に添加される試験菌液は、予め枯草菌(Bacillus subtilis)の培養により得られた枯草菌液を用いて調製し、試験用の除菌液9mlに対して、菌液1mlを接種した。表3に示すように、菌液添加から室温で所定時間作用させた後に、試験液を標準寒天培地にて混釈培養し、菌数を計測した。結果を実施例1~3として、表3に併記する。 500 ml of the high-concentration carbonated water obtained as described above was mixed with the GSE stock solution to obtain a content ratio of 2% by volume to obtain a disinfectant solution for testing. This disinfectant solution for testing was used to conduct an antibacterial test by pour plate culture method to confirm the disinfectant effect against spore-forming bacteria. The test bacteria solution to be added to the disinfectant solution was prepared using a Bacillus subtilis solution obtained in advance by culturing Bacillus subtilis, and 1 ml of the bacteria solution was inoculated into 9 ml of the disinfectant solution for testing. As shown in Table 3, after the addition of the bacteria solution and allowing it to act for a specified time at room temperature, the test solution was pour-cultured on a standard agar medium and the number of bacteria was counted. The results are shown in Table 3 as Examples 1 to 3.

Figure 0007668490000001
Figure 0007668490000001

Figure 0007668490000002
Figure 0007668490000002

Figure 0007668490000003
Figure 0007668490000003

また、比較対照として生理食塩水を用いて、実施例1と同様の操作を行った。結果を、表3中の対照液欄に併記する。表3の結果に示されるように、除菌液を含まない実施例1の対照液では、添加直後の菌数が、1.7×105(/ml)であった。これに対し、実施例1では、対照液と同じ添加直後において、定量下限値未満まで、菌数が低減しており、実施例2、3の1時間後、2時間後についても、同様の結果が得られた。このように、除菌成分としてポリフェノールを含むGSEと、二酸化炭素の微細バブルを含む炭酸水とを混合した除菌液は、芽胞菌に対して高い除菌効果を示すことが確認された。 In addition, the same operation as in Example 1 was performed using physiological saline as a comparative control. The results are shown in the control solution column in Table 3. As shown in the results in Table 3, the control solution of Example 1 not containing a disinfectant solution had a bacterial count of 1.7 x 105 (/ml) immediately after addition. In contrast, in Example 1, the bacterial count was reduced to below the lower limit of quantification immediately after addition, just like the control solution, and similar results were obtained after 1 hour and 2 hours in Examples 2 and 3. In this way, it was confirmed that the disinfectant solution obtained by mixing GSE containing polyphenols as a disinfectant component and carbonated water containing fine bubbles of carbon dioxide exhibits a high disinfecting effect against spore-forming bacteria.

(比較例1~3)
実施例1と同様にして得た高濃度炭酸水500mlに、GSE原液を混合せずに、比較用の試験液とした。この試験液9mlに対して、実施例1と同様に予め調製された菌液1mlを接種し、芽胞菌に対する除菌効果を確認するための抗菌試験を行った。表3に示すように、菌液添加から所定時間作用させた後に、試験液を標準寒天培地にて混釈培養し、菌数を計測した。結果を比較例1~3として、表3に併記する。
(Comparative Examples 1 to 3)
A comparative test solution was prepared by mixing 500 ml of high-concentration carbonated water obtained in the same manner as in Example 1 with no GSE stock solution. 1 ml of the bacterial solution prepared in advance in the same manner as in Example 1 was inoculated into 9 ml of this test solution, and an antibacterial test was carried out to confirm the sterilization effect against spore-forming bacteria. As shown in Table 3, after the bacterial solution was allowed to act for a predetermined time after addition, the test solution was pour cultured on a standard agar medium and the number of bacteria was counted. The results are shown in Table 3 as Comparative Examples 1 to 3.

また、比較対照として生理食塩水を用いて、比較例1と同様の操作を行った。結果を、表3中の対照液欄に併記する。表3の結果に示されるように、比較例1~3は、いずれも菌数が105オーダーで、対照液とほぼ同等であり、高濃度炭酸水のみでは、芽胞菌に対する除菌効果が得られないことが判明した。 As a control, physiological saline was used and the same operation as in Comparative Example 1 was carried out. The results are shown in the control solution column in Table 3. As shown in the results in Table 3, in all of Comparative Examples 1 to 3, the bacterial counts were on the order of 105 , which was almost the same as the control solution, and it was found that high-concentration carbonated water alone was not effective in eliminating spore-forming bacteria.

(比較例4~7)
比較用の試験液として、高濃度炭酸水を混合しないGSE原液を用い、実施例1と同様の芽胞菌に対する抗菌試験を行った。試験液としてのGSE原液30mlに、予め調製された試験菌液0.1mlを加えて混合し、室温で10分、30分、1時間接触後にそのうち1mlを取り、滅菌生理食塩水にて希釈した。この希釈液を、標準寒天培地にて混釈培養し、所定時間後の生菌数を計測した。なお、試験菌液には、枯草菌を培養して芽胞を形成後、加熱により栄養型細菌を死滅させた芽胞菌を使用した。結果を比較例4~7として、表3に併記する。
(Comparative Examples 4 to 7)
As a comparative test solution, a GSE stock solution without high-concentration carbonated water was used, and an antibacterial test against spore-forming bacteria was performed in the same manner as in Example 1. 0.1 ml of a test bacteria liquid prepared in advance was added to 30 ml of the GSE stock solution as a test solution, and mixed. After contact at room temperature for 10 minutes, 30 minutes, and 1 hour, 1 ml of the liquid was taken and diluted with sterile physiological saline. This diluted liquid was pour-cultured on a standard agar medium, and the number of live bacteria was measured after a predetermined time. For the test bacteria liquid, spore-forming bacteria in which vegetative bacteria were killed by heating after culturing Bacillus subtilis to form spores were used. The results are shown in Table 3 as Comparative Examples 4 to 7.

また、比較対照として滅菌精製水を用いて、比較例4、7と同様の操作を行った。結果を、表3中の対照液欄に併記する。表3の結果に示されるように、比較例4~7のGSE原液のみの場合、いずれも菌数が105オーダーと、添加直後又は1時間後の対照液と同等であり、芽胞菌に対する除菌効果は見られないことが判明した。 As a control, sterilized purified water was used, and the same operations as in Comparative Examples 4 and 7 were carried out. The results are also shown in the control solution column in Table 3. As shown in the results in Table 3, in the case of using only the GSE undiluted solution in Comparative Examples 4 to 7, the bacterial count was on the order of 105 , which was equivalent to the control solution immediately after addition or one hour later, and it was found that no sterilization effect against spore-forming bacteria was observed.

(参考例1~3)
参考のため、実施例1で用いたGSE原液について、濃度を変更した試験液を調整し、3種の食中毒菌に対する抗菌試験を行って、効果の有無と効果が表れる濃度を確認した。表4に示すように、試験液として、GSE原液を滅菌水で希釈して、0.1%、0.01%、0.001%水溶液(体積%)としたものを用い、これら試験液9mlに、それぞれ添加用の試験菌液1mlを、添加撹拌した。試験菌液は、大腸菌(Escherichia coli)、サルモネラ属菌(Salmonella spp)、黄色ブドウ球菌(Staphylococcus)の3種について、予め供試菌株を用いて培養したものを所定の菌数レベルとなるように調製したものを用いた。
(Reference Examples 1 to 3)
For reference, test solutions with different concentrations of the GSE stock solution used in Example 1 were prepared and antibacterial tests were conducted against three types of food poisoning bacteria to confirm the presence or absence of an effect and the concentration at which the effect was observed. As shown in Table 4, the test solutions were prepared by diluting the GSE stock solution with sterilized water to 0.1%, 0.01%, and 0.001% aqueous solutions (volume %), and 1 ml of the test bacteria solution for addition was added to each of 9 ml of these test solutions and stirred. The test bacteria solutions were prepared by culturing three types of bacteria, Escherichia coli, Salmonella spp, and Staphylococcus aureus, using test strains in advance and preparing them to have a predetermined bacterial count level.

添加撹拌した直後の試験液について、直ちに標準寒天培地を用いた混釈平板培養法(35±1℃、48時間培養)により、出現した菌数(コロニー数)を計測した。その結果を、表4に併記するように、比較対照となる生理食塩水(対照試料1)については、いずれの菌についても、菌数が105オーダーであった。これに対し、0.1%GSE原液を添加した参考例1は、大腸菌(E.coli)が104オーダーと約一桁の減少を示し、サルモネラ属菌は約二桁の減少を、黄色ブドウ球菌は約五分の一の減少を示した。0.01%、0.001%GSE原液を添加した参考例2、3については、菌数の減少は確認されなかった。 The number of bacteria (colonies) that appeared in the test solution immediately after addition and stirring was counted by pour plate culture method using standard agar medium (cultured at 35±1°C for 48 hours). As shown in Table 4, the number of bacteria was on the order of 10 for all bacteria in the physiological saline solution (control sample 1) used as a comparison control. In contrast, in Reference Example 1, which was added with 0.1% GSE stock solution, Escherichia coli (E. coli) was reduced by about one order of magnitude to 10 , Salmonella spp. was reduced by about two orders of magnitude, and Staphylococcus aureus was reduced by about one-fifth. No reduction in the number of bacteria was confirmed in Reference Examples 2 and 3, which were added with 0.01% and 0.001% GSE stock solutions.

Figure 0007668490000004
Figure 0007668490000004

表4の結果を踏まえて、GSE原液の含有量が2.0%(体積%)の試験液を調製し、作用時間を変更した参考例4~6について、同様の抗菌試験を行った。試験液9mlに、3種の菌の添加用の試験菌液1mlを、それぞれ添加撹拌し、添加直後、1時間作用後(室温)、2時間作用後(室温)に、混釈平板培養法により菌数を計測した。結果を、比較対照のための対照試料2~4の結果と共に、表4に併記する。 Based on the results in Table 4, a test solution containing 2.0% (volume %) GSE stock solution was prepared, and a similar antibacterial test was carried out for Reference Examples 4 to 6 in which the reaction time was changed. 1 ml of the test bacteria solution for adding the three types of bacteria was added to 9 ml of the test solution and stirred, and the number of bacteria was measured using the pour plate culture method immediately after addition, after 1 hour of reaction (room temperature), and after 2 hours of reaction (room temperature). The results are shown in Table 4, along with the results of control samples 2 to 4 for comparison.

表4に示されるように、対照試料2~4は、いずれの菌についても、菌数が105オーダーで作用時間による変化も見られなかった。これに対し、2.0%GSE原液を添加した参考例4~6は、大腸菌(E.coli)、サルモネラ属菌について、添加直後から菌数が10以下となった。黄色ブドウ球菌は、添加直後の菌数は40(/ml)であったものの、1時間作用後、2時間作用後には10以下となり、菌が検出されなくなった。 As shown in Table 4, in Control Samples 2 to 4, the bacterial counts for all bacteria were on the order of 105 , and no change was observed with time of action. In contrast, in Reference Examples 4 to 6, in which 2.0% GSE stock solution was added, the bacterial counts for Escherichia coli (E. coli) and Salmonella spp. were 10 or less immediately after addition. For Staphylococcus aureus, the bacterial count was 40 (/ml) immediately after addition, but after 1 and 2 hours of action, it was 10 or less, and the bacteria were no longer detectable.

(参考例7~9)
参考のため、実施例1で用いたGSE原液について、腸管出血性大腸菌O157(以下、O157)に対する抗菌試験を行った。試験液として、GSE原液9mlに、予め保存菌株を用いて調製された添加用の試験菌液1mlを接種して、表5に示すように、菌液添加から所定時間作用させた。その後、試験液を標準寒天培地にて混釈培養し(35℃、24±2時間)、菌数を計測した。結果を参考例7~9として、生理食塩水を用いた対照液の結果と共に、表5に併記する。
(Reference Examples 7 to 9)
For reference, the GSE stock solution used in Example 1 was subjected to an antibacterial test against enterohemorrhagic Escherichia coli O157 (hereinafter, O157). As the test solution, 1 ml of a test bacterial solution for addition, which had been prepared in advance using a preserved bacterial strain, was inoculated into 9 ml of the GSE stock solution, and the solution was allowed to act for a predetermined time from the addition of the bacterial solution, as shown in Table 5. The test solution was then pour cultured on a standard agar medium (35°C, 24±2 hours), and the number of bacteria was counted. The results are shown in Table 5 as Reference Examples 7 to 9, together with the results of a control solution using physiological saline.

Figure 0007668490000005
Figure 0007668490000005

表5の結果に示されるように、GSE原液のみの試験液でも、添加直後からO157に対する除菌効果が見られ、定量下限値未満に減少した。 As shown in the results in Table 5, even the test solution containing only the GSE concentrate showed a sterilizing effect against O157 immediately after addition, reducing it below the lower limit of quantification.

(参考例10~12)
参考のため、実施例1で用いたGSE原液について、MRSA(methicillin‐resistant Staphylococcus aureus;メチシリン耐性黄色ブドウ球菌)に対する抗菌試験を行った。試験液として、GSE原液10mlに、予め調製された試験菌液0.1mlを添加して、表5に示す所定時間反応させた後、LP希釈液で100倍に希釈して反応を停止した。次いで、そのうち1mlを取り出し、9mlの希釈用生理食塩水に混合して、10倍に希釈した。この希釈液を、標準寒天培地にて混釈培養し(37℃で48時間)、コロニー数を計測して生菌数を求めた。なお、試験菌液には、予め保存菌を培養して培地成分を除去し、精製水で所定の菌数範囲に調製されたものを用いた。結果を参考例10~12として、表6に併記する。
(Reference examples 10 to 12)
For reference, the GSE stock solution used in Example 1 was subjected to an antibacterial test against MRSA (methicillin-resistant Staphylococcus aureus). 0.1 ml of a test bacteria solution prepared in advance was added to 10 ml of the GSE stock solution as a test solution, and the test solution was reacted for a predetermined time shown in Table 5, and then diluted 100 times with LP dilution solution to stop the reaction. Next, 1 ml of the test solution was taken out and mixed with 9 ml of dilution saline to dilute 10 times. This diluted solution was mixed and cultured on a standard agar medium (at 37°C for 48 hours), and the number of colonies was counted to determine the viable cell count. The test bacteria solution was prepared by culturing a stock bacteria in advance to remove medium components and then adjusting the bacteria count to a predetermined range with purified water. The results are shown in Table 6 as Reference Examples 10 to 12.

Figure 0007668490000006
Figure 0007668490000006

また、滅菌精製水を用いた対照液について、同様の試験行った結果を、表6に併記する。対照液については、参考例10~12と同じ所定時間(1分、5分、10分)反応させた場合と共に、接種直後の菌数を対照試料5として併せて示した。 The results of a similar test performed on a control solution using sterilized purified water are also shown in Table 6. For the control solution, the results are shown for the same specified times (1 minute, 5 minutes, and 10 minutes) as in Reference Examples 10 to 12, as well as the number of bacteria immediately after inoculation as control sample 5.

表6の結果に示されるように、対照試料2は接種直後からの菌数が大きく変化していないのに比べて、参考例10~12のように、GSE原液を含む試験液では、1分の反応でMRSAに対する明らかな除菌効果が見られ、10分の反応で生菌数が100未満(/ml)に減少した。 As shown in the results in Table 6, in the case of control sample 2, the number of bacteria did not change significantly immediately after inoculation, whereas in the case of the test solutions containing GSE concentrate, as in Reference Examples 10 to 12, a clear sterilization effect against MRSA was observed in a reaction of 1 minute, and the number of viable bacteria decreased to less than 100 (/ml) in a reaction of 10 minutes.

(参考例13~20)
参考のため、実施例1で用いたGSE原液について、インフルエンザウイルス(Influenza A virus)及びネコカリシウイルス(Feline calicivirus)に対するウイルス不活性化試験を行った。試験液として、GSE原液を用い、ウイルス液を添加混合した作用液について、所定時間後(室温)のウイルス感染価を測定した。表7に示すように、インフルエンザウイルスは、作用開始の直後、10分後、1時間後、3時間後の作用液について、それぞれ測定を行った。また、ネコカリシウイルスは、作用開始の直後、15秒後、1分後、10分後の作用液について、それぞれ測定を行った。これらの結果を、参考例13~16、参考例17~20として、対照液(精製水)の結果と共に、表7に併記する。
(Reference examples 13 to 20)
For reference, a virus inactivation test against influenza A virus and feline calicivirus was performed on the GSE stock solution used in Example 1. The GSE stock solution was used as the test solution, and the virus solution was added and mixed to the working solution, and the virus infectivity was measured after a predetermined time (room temperature). As shown in Table 7, the influenza virus was measured for the working solution immediately after the start of the action, 10 minutes later, 1 hour later, and 3 hours later. The feline calicivirus was measured for the working solution immediately after the start of the action, 15 seconds later, 1 minute later, and 10 minutes later. These results are shown in Table 7 as Reference Examples 13 to 16 and Reference Examples 17 to 20, together with the results of the control solution (purified water).

なお、ネコカリシウイルスは、ノロウイルスの代替ウイルスである。ウイルス液は、細胞培養液のウイルス培養液を遠心分離して得られた上澄み液を、精製水で10倍希釈したものであり、このウイルス液0.1mlを試験液1mlに添加した作用液について、室温で所定時間作用させた後、細胞維持培地で1000倍に希釈した。ウイルス感染価(log TCID50/ml)は、TCID50(median tissue culture infectious dose)法に基づいて測定された、50%組織培養感染量である。 Feline calicivirus is an alternative virus to norovirus. The virus solution was prepared by centrifuging a virus culture solution of a cell culture and diluting the supernatant 10-fold with purified water. 0.1 ml of this virus solution was added to 1 ml of test solution to prepare an action solution, which was allowed to act at room temperature for a predetermined time, and then diluted 1000-fold with cell maintenance medium. The virus infectivity (log TCID 50 /ml) is the 50% tissue culture infectious dose measured based on the TCID 50 (median tissue culture infectious dose) method.

Figure 0007668490000007
Figure 0007668490000007

表7に示すように、インフルエンザウイルスは、10分作用後の参考例14において、ウイルス感染価が4.5未満(log TCID50/ml)となり、ネコカリシウイルスは、15秒後の参考例18において、ウイルス感染価が3.5未満(log TCID50/ml)となり、ウイルスが検出されなくなった。 As shown in Table 7, in Reference Example 14, the viral infectivity of influenza virus was less than 4.5 (log TCID 50 /ml) after 10 minutes of exposure, and in Reference Example 18, the viral infectivity of feline calicivirus was less than 3.5 (log TCID 50 /ml) after 15 seconds, and the virus was no longer detectable.

(参考例21)
参考のため、実施例1で用いたGSE原液について、OECD化学物質毒性試験指針(1987)に準拠し、マウスにおける急性経口毒性試験(限度試験)を行った。GSE原液を精製水で1000倍に希釈した試験液を用い、試験群となる雌雄マウスに、20ml/kgの用量で単回経口投与したところ、試験後の観察期間において異常は認められず、対照群との体重増加に差は見られなかった。なお、対照群となる雌雄マウスには、試験液に代えて、精製水0.7ml又は0.6mlを投与し、観察期間は14日間とした。
(Reference Example 21)
For reference, the GSE stock solution used in Example 1 was subjected to an acute oral toxicity test (limit test) in mice in accordance with the OECD Guidelines for Toxicity Testing of Chemical Substances (1987). The GSE stock solution was diluted 1000 times with purified water, and the test solution was orally administered to male and female mice in a single dose of 20 ml/kg. No abnormalities were observed during the observation period after the test, and no difference was observed in weight gain compared to the control group. The control group of male and female mice was administered 0.7 ml or 0.6 ml of purified water instead of the test solution, and the observation period was 14 days.

また、参考のため、実施例1で用いたGSE原液について、食品に残留する農薬、飼料添加物又は動物用医薬品の成分である物質の試験法について」(平成17年1月24日付食安発第0124001号)に基づく試験を行ったところ、全ての検査項目について、次検出であった。 For reference, the GSE concentrate used in Example 1 was tested according to "Testing Methods for Pesticides, Feed Additives, or Veterinary Drug Ingredients Residual in Food" (Notification No. 0124001 from the Food Safety Bureau dated January 24, 2005), and the following were detected in all test items:

以上の結果から、GSE原液については、動物に対する急性の経口毒性は見られず、残留農薬等も検出されていない。GSE原液を炭酸水と混合して得られる除菌液についても、同様と考えられるから、このような除菌液を、従来の消毒液等に代えて用いることにより、除菌性能と安全性の両立が可能になる。 The above results show that GSE concentrate does not pose any acute oral toxicity to animals, and no residual pesticides have been detected. The same is likely true for the disinfectant solution obtained by mixing GSE concentrate with carbonated water, so by using such a disinfectant solution in place of conventional disinfectants, it will be possible to achieve both disinfecting performance and safety.

このような除菌液は、天然由来の成分であるGSEと炭酸水のみを含み、人体への影響が少ない弱酸性の水溶液であるので、安全であるのみならず取扱性にも優れている。また、除菌成分を含むGSEと微細バブル状の二酸化炭素が溶存する炭酸水とを組み合わせることにより、種々の菌やウイルスに対して高い除菌効果を示し、しかも、安定した品質を長期間維持するとことが可能になる。 This type of disinfectant solution contains only GSE, a naturally derived ingredient, and carbonated water, and is a weakly acidic aqueous solution that has little effect on the human body, making it not only safe but also easy to handle. Furthermore, by combining GSE, which contains disinfectant ingredients, with carbonated water in which fine carbon dioxide bubbles are dissolved, it exhibits a high disinfecting effect against various bacteria and viruses, and can also maintain stable quality for a long period of time.

本発明は、上記した実施形態や実施例に限定されるものではなく、その要旨を逸脱しない範囲において種々の実施形態に適用することが可能である。 The present invention is not limited to the above-described embodiments and examples, and can be applied to various embodiments without departing from the spirit of the present invention.

Claims (7)

微細バブルを含む炭酸水と、グレープフルーツ種子抽出物の原液との混合液からなり、
上記炭酸水は、二酸化炭素濃度が300mg/L以上の高濃度炭酸水であり、
上記グレープフルーツ種子抽出物の原液は、1mg/100g以上のポリフェノール及び30mg/100g以上のクエン酸を含むものであり、
上記混合液は、pHが7未満であり、
上記混合液における、上記グレープフルーツ種子抽出物の原液の配合割合が、1体積%以上である、除菌液。
It is made of a mixture of carbonated water containing fine bubbles and a concentrate of grapefruit seed extract.
The carbonated water is high-concentration carbonated water having a carbon dioxide concentration of 300 mg/L or more.
The grapefruit seed extract concentrate contains 1 mg/100 g or more of polyphenols and 30 mg/100 g or more of citric acid,
The mixture has a pH of less than 7;
A disinfecting solution, in which the blending ratio of the grapefruit seed extract concentrate in the mixed solution is 1 volume % or more .
上記炭酸水は、二酸化炭素濃度が1000mg/L以上1300mg/L以下の高濃度炭酸水である、請求項1に記載の除菌液。 The disinfectant solution according to claim 1, wherein the carbonated water is high-concentration carbonated water having a carbon dioxide concentration of 1000 mg/L or more and 1300 mg/L or less . 上記微細バブルは、粒子径1μm未満のナノバブルを含む、請求項2に記載の除菌液。 The disinfectant solution according to claim 2 , wherein the fine bubbles include nanobubbles having a particle diameter of less than 1 μm . 上記混合液における、グレープフルーツ種子抽出物の配合割合が、2体積%以上である、請求項1~3のいずれか1項に記載の除菌液。 The disinfectant solution according to any one of claims 1 to 3 , wherein the blending ratio of grapefruit seed extract in the mixed solution is 2 volume% or more . 上記混合液は、pHが4.5以上6以下である、請求項1~4のいずれか1項に記載の除菌液。 The disinfectant solution according to any one of claims 1 to 4 , wherein the mixed solution has a pH of 4.5 or more and 6 or less . 上記グレープフルーツ種子抽出物の原液は、脂肪酸を、さらに含む、請求項1~5のいずれか1項に記載の除菌液。 The disinfecting solution according to any one of claims 1 to 5, wherein the grapefruit seed extract concentrate further contains a fatty acid . 芽胞を形成する細菌である芽胞菌の除去を用途とする、請求項1~6のいずれか1項に記載の除菌液。 The disinfectant solution according to any one of claims 1 to 6 , which is intended for the removal of spore-forming bacteria, which are spore-forming bacteria .
JP2021169593A 2021-10-15 2021-10-15 Disinfectant Active JP7668490B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021169593A JP7668490B2 (en) 2021-10-15 2021-10-15 Disinfectant
PCT/JP2022/038075 WO2023063361A1 (en) 2021-10-15 2022-10-12 Disinfection liquid
TW111138978A TW202330008A (en) 2021-10-15 2022-10-14 Disinfection liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021169593A JP7668490B2 (en) 2021-10-15 2021-10-15 Disinfectant

Publications (3)

Publication Number Publication Date
JP2023059530A JP2023059530A (en) 2023-04-27
JP2023059530A5 JP2023059530A5 (en) 2024-11-13
JP7668490B2 true JP7668490B2 (en) 2025-04-25

Family

ID=85988645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021169593A Active JP7668490B2 (en) 2021-10-15 2021-10-15 Disinfectant

Country Status (3)

Country Link
JP (1) JP7668490B2 (en)
TW (1) TW202330008A (en)
WO (1) WO2023063361A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7490901B1 (en) 2024-01-05 2024-05-27 竹本容器株式会社 Carbon dioxide nanobubble water or carbon dioxide nanobubble mist, and its manufacturing method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928573A (en) 1996-05-01 1999-07-27 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Method of disinfecting fresh vegetables by processing the same with a liquid containing a mixture of argon:carbon dioxide
WO2013129245A1 (en) 2012-02-29 2013-09-06 サンスター技研株式会社 Bactericidal agent composition
JP2018075240A (en) 2016-11-10 2018-05-17 国立大学法人 東京大学 CO2 micro / nano bubble water generated in water released to the atmosphere by pressurization at several atmospheric pressures for sterilizing microorganisms, bacteriostatic and controlling insects and pests

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0640834A (en) * 1991-01-30 1994-02-15 Calfa Chem Kk Spray comprising natural antimicrobial substance and its production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928573A (en) 1996-05-01 1999-07-27 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Method of disinfecting fresh vegetables by processing the same with a liquid containing a mixture of argon:carbon dioxide
WO2013129245A1 (en) 2012-02-29 2013-09-06 サンスター技研株式会社 Bactericidal agent composition
JP2018075240A (en) 2016-11-10 2018-05-17 国立大学法人 東京大学 CO2 micro / nano bubble water generated in water released to the atmosphere by pressurization at several atmospheric pressures for sterilizing microorganisms, bacteriostatic and controlling insects and pests

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
食衛誌,2008年,Vol. 49, No. 1,pp. 56-62

Also Published As

Publication number Publication date
JP2023059530A (en) 2023-04-27
WO2023063361A1 (en) 2023-04-20
TW202330008A (en) 2023-08-01

Similar Documents

Publication Publication Date Title
US5425944A (en) Antimicrobial grapefruit extract
US10813353B2 (en) Antimicrobial compositions
TWI578909B (en) Fungicide composition
JP6803896B2 (en) Antimicrobial agent containing hypochlorous acid
CN108605933B (en) Fatty acid compound
NO149232B (en) SPORICID, PERCARBOXYLIC ACID CONTAINING DISINFECTANT IN THE FORM OF AN ALCOHOLIC OR Aqueous ALCOHOLIC SOLUTION
JP6025262B2 (en) Synergistic disinfecting composition comprising essential oil
KR102201176B1 (en) Method for Preparing Disinfectant Containing Natural Fruit Extract and Organic Acid
CN103929967A (en) Disinfectant composition and its application
JP7058490B2 (en) Antibacterial composition that suppresses viruses, bacteria and fungi
JP7668490B2 (en) Disinfectant
CN115176809A (en) Antimicrobial agent comprising hypochlorous acid
CN106309412A (en) Compound ethanol disinfectant
JP2004509636A (en) Water-based disinfectant / disinfectant for food
JP6310745B2 (en) Bactericidal composition
US20060075922A1 (en) Controlled-acidity composition
CN113940358B (en) Efficient alcohol-free guanidine compound disinfectant and preparation method thereof
CN111328811B (en) A kind of low-concentration alcohol sterilizing and disinfecting liquid and its application
CN103843764B (en) A kind of strengthening modified glutaraldehyde disinfectant solution and preparation method thereof
RU2481126C1 (en) Disinfectant
US20250241316A1 (en) Surface treatment composition comprising both chemical and microbial components for surpressing non-gras microorganisms on a surface, to the benefit of gras microorganisms
US20110008469A1 (en) Antimicrobial composition and methods and apparatus for use thereof
JP2022102189A (en) Antibacterial and antiviral drugs
AU2025200561A1 (en) Surface treatment composition comprising both chemical and microbial components for surpressing non-gras microorganisms on a surface, to the benefit of gras microorganisms
CN116671527A (en) A kind of jatropha compound disinfectant and preparation method thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240924

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240924

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250325

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250404

R150 Certificate of patent or registration of utility model

Ref document number: 7668490

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150